Cargando…
MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL
BACKGROUND: MicroRNAs are known to inhibit gene expression by binding to the 3′UTR of the target transcript. Downregulation of miR-223 has been recently reported to have prognostic significance in CLL. However, there is no evidence of the pathogenetic mechanism of this miRNA in CLL patients. METHODS...
Autores principales: | Rodríguez-Vicente, Ana E, Quwaider, Dalia, Benito, Rocío, Misiewicz-Krzeminska, Irena, Hernández-Sánchez, María, de Coca, Alfonso García, Fisac, Rosa, Alonso, José-María, Zato, Carolina, de Paz, Juan Francisco, García, Juan Luis, Sarasquete, Ma Eugenia, Hernández, José Ángel, Corchado, Juan M, González, Marcos, Gutiérrez, Norma C, Hernández-Rivas, Jesús-María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404064/ https://www.ncbi.nlm.nih.gov/pubmed/25880332 http://dx.doi.org/10.1186/s12885-015-1212-2 |
Ejemplares similares
-
DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
por: Quwaider, Dalia, et al.
Publicado: (2017) -
Factors Regulating microRNA Expression and Function in Multiple Myeloma
por: Misiewicz-Krzeminska, Irena, et al.
Publicado: (2019) -
Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14
por: Rodríguez, Ana Eugenia, et al.
Publicado: (2012) -
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
por: Quijada-Álamo, Miguel, et al.
Publicado: (2020) -
CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
por: Hernández-Sánchez, María, et al.
Publicado: (2018)